Ryan Gill is a Professor in the Department of Chemical and Biological Engineering at CU Boulder and is the Associate Director for Research at RASEI. He was the founding Managing Director at the Colorado Center for Biorefining and Biofuels (C2B2) and was co-founder and board member at OPXBio.
Research InterestsDirected Genome Evolution: New Tools and Applications
Our research falls within the general fields of metabolic engineering, synthetic biology, directed evolution, and genomics and is targeted primarily towards the development biorefining processes for the sustainable production of fuels, commodity chemicals, and pharmaceuticals. We are generally focused on the development of new i) tools for strain engineering (i.e. genome engineering), ii) methods for efficiently determining the genetic basis of so engineered strains (i.e. functional genomics), and iii) frameworks for rationalizing relationships identified between genome structure and function. Our specific projects include:
• Creation, development, and demonstration of novel genome-engineering tools.
• Metabolic engineering for sustainable and fungible bio-diesel production
• Metabolic engineering for sustainable and fungible bio-gasoline production
• Creation, development, and demonstration of new approaches for antimicrobial discovery
• Genome-engineering to improve cellulosic biofuels production
Our research is supported through a number of sources including current or previous grants from the NSF, NIH, DOE, State of Colorado, University of Colorado, Colorado Center for Biorefining and Biofuels, the Cystic Fibrosis Foundation, Agilent, Shell, Dupont, and Opx Bioproducts.
To find out more, visit his website: http://www.gillgroup.org/